A 35-seat subordinated bridge financing into a multi-year intellectual-property enforcement matter. Contingent on litigation recovery. Senior to the Company's own equity. Available only to verified accredited investors.
*Maximum contingent return per Unit. Payable only from Litigation Proceeds in accordance with the contractual waterfall. Not a projection or guarantee of recovery. Litigation is inherently uncertain; total loss of subscribed capital is possible.
The Math Is Set By The Cap, Not By Hope.
Subscribers occupy Tier 3 of a four-tier contractual waterfall — senior to the Company's own equity, behind only the primary funder and law firm. Even at the lowest credible post motion to dismiss ("MTD") settlement floor, the entire Tier-3 obligation clears in full with substantial headroom flowing to the Company's tier.
Years of Documented Work. Not a Pitch.
A Years-Long Documentary Build
A 292-page Confidential Due Diligence Binder with a locked exhibit-correlation matrix — every paragraph of the draft complaint mapped to documentary appendix items, removing substantially all pre-filing investigation cost for counsel.
Top-Tier Firm, Independently Diligenced
A leading nationally-recognized litigation firm has completed independent diligence and is positioned to take the matter forward on a contingent-fee basis — conditional only on bridge close and primary funding placement.
A Public, Market-Based Damages Anchor
A recent SEC F-1 disclosure by a separate public company provides a public, market-based anchor for the damages model and materially strengthens the timeliness of the claims under controlling Second Circuit precedent.
Three Steps. One Secured Unit.
Sign the PBFSA via tamper-evident electronic envelope.
Wire $10,000 to independent bonded custody — released only on Unit Certificate acceptance.
Confirm Rule 501(a) accredited status. The first ten Subscribers have their verification fee covered.
35 Units. One Clock.
Your free account unlocks the complete diligence package — no payment or commitment required to review.